Could a patent get in between you and a Covid-19 test? Yes
Share
In 2001, the United States faced a credible threat of an anthrax outbreak, yet Bayer refused to license its patents on ciprofloxacin (Cipro), the most effective antibiotic treatment for anthrax, to competitors, even as Bayer itself struggled to supply the nation’s antibiotic stockpile.Featured Publications
Spotlight on Criminal Justice: Observing PTACC National Deflection Week – July
Senate Spending Spree Same As It Ever Was
Legislative Lessons: How Three States Improved Access to HIV Prevention Medications
This IVF bill is a perfectly reasonable compromise. So, of course, Congress won’t pass it.